Clinical Trial 22561

• Overview

  Study Title:

  Minority Patient-Centered Education Initiative to Increase Knowledge About Clinical Trials in Thoracic Oncology

  Summary:

  The purpose of this Study is for the development and assessment of culturally tailored patient-centered videos for Black and Hispanic/Latino patients to increase education about clinical trials in thoracic oncology.

  Objective:

  Aim 1: To develop two culturally tailored patient-centered videos for Black and Hispanic/Latino patients to increase education about clinical trials in thoracic oncology. Each video will last no longer than 5 minutes and the content will include: 1) historical background and acknowledgment of past research misconduct by investigators toward minority populations, 2) rates of minority patient participation in clinical research, 3) description of a thoracic oncology clinical trial, 4) the importance of clinical trials for new treatment and new drug development for racial/ethnic minority individuals, and 5) how to talk to your doctor about clinical trials. Given the nature of these videos (tailored based upon racial/ethnic minority group), the historical background for each video will be distinct, and the video for Hispanic/Latino patients will be in Spanish. Aim 2: To assess the feasibility and acceptability of the two patient-centered educational videos. Our working hypothesis is that the videos implementation will be feasible and that Black and Hispanic/Latino patients will rate the videos positively. Minority patients will be pre-screened before they come for their clinical appointment. Those eligible and consenting will be given an iPad upon arrival for appointment, complete a short pre-test survey, watch the video, complete a short post-video survey. A second post-video survey will also be completed 6 months later. Feasibility and acceptability metrics have been described in the approach section.

• Inclusion Criteria

  Inclusion Criteria:
  • Provision of signed and dated informed consent document
  • Suspected or confirmed diagnosis of lung cancer, including non- small cell lung cancer, small cell lung cancer, large cell neuroendocrine carcinoma of the lung, high grade neuroendocrine carcinoma of the lung
  • Suspected or confirmed clinical stages I-IV
  • Participant must be in good general health as evidenced by medical history with an Eastern Cooperative Oncology Group (ECOG) Performance Status 0-2
  • Participant must be 18 years of age or older
  • Participant must self-identify as Black or Hispanic/Latino
  • Participant must be able to understand English or Spanish
  • Participant must have a working phone, computer, or tablet

• Exclusion Criteria

  Exclusion Criteria:
  • Enrollment in a therapeutic clinical trial at the time of Informed Consent (ICF) signature. Patients may enroll into a therapeutic clinical trial at a later time as long as it occurs after ICF signature for this study and baseline survey completion.

If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.